Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pracht

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Progress in Tumor Research|April 15, 2014
Successes and limitations of targeted therapies in renal cell carcinomaMarc Pracht, Dominik Berthold
Revue Medicale Suisse|June 14, 2013
[Immunotherapy: a therapeutic revolution against prostate cancer?]Marc Pracht, Fernanda Herrera, Thomas Tawadros, et al.
Journal of Hepatocellular Carcinoma|August 31, 2016
Hepatocellular carcinoma in elderly patients: challenges and solutionsAngélique Brunot, Samuel Le Sourd, Marc Pracht, et al.
Journal of Gastrointestinal Cancer|May 29, 2010
Clubbing and hypertrophic osteoarthropathy in two patients taking long-term bevacizumab for metastatic colorectal cancerMarc Pracht, Catherine Le Roux, Mallorie Kerjouan, et al.
The Journal of Surgical Research|November 28, 2012
Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resectionLaurent Sulpice, Michel Rayar, Eveline Boucher, et al.
Cardiovascular and Interventional Radiology|April 2, 2015
How to Prepare a Patient for Transarterial Radioembolization? A Practical GuideAlban Denys, Marc Pracht, Rafael Duran, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 25, 2015
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line ViabilityJulien Edeline, Cédric Coulouarn, Laurence Crouzet, et al.
Medical Oncology (Northwood, London, England)|October 12, 2010
Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancerCatherine Leroux, Elodie Vauléon, Marc Pracht, et al.
Cancer|June 30, 2011
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinomaJulien Edeline, Eveline Boucher, Yan Rolland, et al.
Bulletin Du Cancer|March 12, 2018
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Progress in Tumor Research|April 15, 2014
Successes and limitations of targeted therapies in renal cell carcinomaMarc Pracht, Dominik Berthold
Revue Medicale Suisse|June 14, 2013
[Immunotherapy: a therapeutic revolution against prostate cancer?]Marc Pracht, Fernanda Herrera, Thomas Tawadros, et al.
Journal of Hepatocellular Carcinoma|August 31, 2016
Hepatocellular carcinoma in elderly patients: challenges and solutionsAngélique Brunot, Samuel Le Sourd, Marc Pracht, et al.
Journal of Gastrointestinal Cancer|May 29, 2010
Clubbing and hypertrophic osteoarthropathy in two patients taking long-term bevacizumab for metastatic colorectal cancerMarc Pracht, Catherine Le Roux, Mallorie Kerjouan, et al.
The Journal of Surgical Research|November 28, 2012
Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resectionLaurent Sulpice, Michel Rayar, Eveline Boucher, et al.
Cardiovascular and Interventional Radiology|April 2, 2015
How to Prepare a Patient for Transarterial Radioembolization? A Practical GuideAlban Denys, Marc Pracht, Rafael Duran, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 25, 2015
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line ViabilityJulien Edeline, Cédric Coulouarn, Laurence Crouzet, et al.
Medical Oncology (Northwood, London, England)|October 12, 2010
Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancerCatherine Leroux, Elodie Vauléon, Marc Pracht, et al.
Cancer|June 30, 2011
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinomaJulien Edeline, Eveline Boucher, Yan Rolland, et al.
Bulletin Du Cancer|March 12, 2018
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Pageof 6